Advertisement · 728 × 90
#
Hashtag
#OncotypeDX
Advertisement · 728 × 90
Onco404
Onco404
@onco404.bsky.social
10 months ago

🔍 Why It Matters
☑️ 20% of HR+/HER2- EBC patients relapse despite adjuvant C-ET.
✅ Existing tools (e.g., 21-gene, 70-gene) guide chemo decisions but fail to pinpoint high-risk patients after C-ET.

#Onco404 #Cancer #Kanser #BreastCancer #MemeKanseri #OncotypeDX #MammaPrint #Prosigna #OncSky #MedSky

1 0 1 0
Onco404
Onco404
@onco404.bsky.social
10 months ago
Post image Post image Post image

A 10-gene signature can now predict recurrence risk for HR+/HER2- early breast cancer #EBC patients post-chemo-endocrine therapy.

@myesmo.bsky.social @breastcancerorg.bsky.social

#Onco404 #Cancer #Kanser #BreastCancer #MemeKanseri #OncotypeDX #MammaPrint #EndoPredict #Prosigna #PAM50 #GGI #MedSky

1 1 1 0